CODX vs CVX · rev $3.9M vs P/E 17, rev $189.03B
Co-Diagnostics, Inc. Common Stock (CODX) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported CVX revenue for 2025-12-31 was $189.03B. Net income was $12.30B. Revenue was down 6.8% from 2024-12-31 to 2025-12-31. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
CODX currently screens at market cap $31.4M. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the CODX and CVX stock pages for the full models.
Not investment advice.